Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Investigating Outcomes That Matter and the Suitability of PROMs for Older People Living With Frailty
Authors not listed
Royal Devon and Exeter NHS Foundation Trust · 2023
Abstract
The goal of this qualitative study is to investigate what matters to older people living with frailty, and how this can be measured using questionnaires (Patient Reported Outcome Measures, or "PROMs").
The research questions are:
1. What outcomes matter to older adults living with frailty?
2. What are participants' perceptions of PROMs that could measure these outcomes?
Our estimated sample will be 15 older adults, approximately 5 people living with mild frailty, 5 living with moderate frailty and 5 living with severe frailty. Participants will take part in one 90-minute interview.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-10-24 MST
Cite this
APA
Anonymous. (2023). Investigating Outcomes That Matter and the Suitability of PROMs for Older People Living With Frailty. <em>Royal Devon and Exeter NHS Foundation Trust</em>. https://clinicaltrials.gov/study/NCT06099691
Vancouver
Anonymous. Investigating Outcomes That Matter and the Suitability of PROMs for Older People Living With Frailty. Royal Devon and Exeter NHS Foundation Trust. 2023.
BibTeX
@misc{anon2023Invest,
title = {Investigating Outcomes That Matter and the Suitability of PROMs for Older People Living With Frailty},
author = {Anonymous},
journal = {Royal Devon and Exeter NHS Foundation Trust},
year = {2023},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Innovation in aging 2025
Open access · OA
METFORMIN TO TARGET FRAILTY IN OLDER ADULTS
Meribank Biotech Co., Ltd. 2024
Open access · US-GOV
A Two-part, Phase I/II, Randomized, Single-blind Study to Evaluate the Efficacy and Safety of UMC119-06-05 in Older Adults With Pre-frailty & Frailty
Ji Yan Biomedical Co., Ltd. 2026
Open access · US-GOV
A Phase 1, Randomized, Double-blind, Placebo-controlled, Dose-Escalation Study to Evaluate the Safety and Tolerability of Stemis™ Administered Intravenously in Elderly Subjects With Mild to Moderate Frailty Syndrome
Chang Chang Cheng 2025
Open access · US-GOV
Quantified Evaluation of Noninvasive System Delivering Microwave Energy for Unwanted Fat Reduction and Skin Tightening in Asians.
New England Journal of Medicine 2024
Preprint · OA
Frailty in Older Adults
University of Leicester 2023
Open access · US-GOV